Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by drippingsnoton Sep 15, 2020 10:29am
80 Views
Post# 31559502

RE:RE:RE:RE:RE:RE:2025 price target

RE:RE:RE:RE:RE:RE:2025 price target Very honestly Benny, I don't think they care about share price on a day-to-day basis.
They have never cared about share price on a day-to-day basis.
That's what I admire about this team - a strong conviction on how to create it.
They too will continue to accumulate cheap shares and one day, it will prove beneficial.
Same old successful Goodman story - IMO.

What are the quotes that come from Goodman's mouth?

"I won't sell one share until I sell them all."
He said it at Paladin and he's saying it again at Knight - he is consistent.

"Mighty oaks from little acorns grow."
He's building GUD's future - using PLB as the blueprint.
If you focus on their size each and every day, you won't see much change.
If you look back, you see some amazing things.

-----------

Let's do that ... what do the past 6 years look like ... from a business development point-of-view
1.  Went to the TSX venture
2.  Within 12 months, went to the TSX big board
3.  Applied, received and sold a PRV for $140M
4.  Made bank on $800M - including the PRV
5.  Canadian Drug licenses and opportunities - 20+ - with only 5 employees working on developing the company (or something like that)
6.  Entered LATAM in a big way and still have $400M in the bank - gone from 5 employees to 700 (or something like that)

It's a pretty impressive look back but very boring at any given moment in time.

I'm not defending - I'm pointing out the Goodman way - he is very boring at any given moment.
It's exactly the way he did it once before ... with the exact same effect on share price (so far).
It's a very important realization ... once you get there (IMO).

Just saying.


<< Previous
Bullboard Posts
Next >>